These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15499166)

  • 1. Relationship between pharmacokinetic parameters and occurrence of adverse events in clinical trials performed in Europe and United States for an angiotensin II receptor antagonist, telmisartan.
    Tatami S; Sarashina A; Yamamura N; Igarashi T; Tanigawara Y
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):24-32. PubMed ID: 15499166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
    Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
    Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of telmisartan in healthy Chinese subjects after oral administration of two dosage levels.
    Zhang P; Zhang Y; Chen X; Li R; Yin J; Zhong D
    Arzneimittelforschung; 2006; 56(8):569-73. PubMed ID: 17009837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
    Stangier J; Su CA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge.
    Stangier J; Su CA; van Heiningen PN; Meinicke T; van Lier JJ; de Bruin H; Tamminga WJ; Jonkman JH
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):672-85. PubMed ID: 11602814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method.
    Tatami S; Yamamura N; Sarashina A; Yong CL; Igarashi T; Tanigawara Y
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):15-23. PubMed ID: 15499165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Pharmacokinetic Interaction between Telmisartan and Chlorthalidone in Healthy Male Adult Subjects.
    Seong SJ; Lim MS; Lee J; Ohk B; Gwon MR; Kim BK; Kim HJ; Yang DH; Lee HW; Kang WY; Yoon YR
    Clin Drug Investig; 2016 Aug; 36(8):613-23. PubMed ID: 27206575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension.
    Bajcetic M; Benndorf RA; Appel D; Schwedhelm E; Schulze F; Riekhof D; Maas R; Böger RH
    J Clin Pharmacol; 2007 Mar; 47(3):295-304. PubMed ID: 17322141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers.
    Stangier J; Su CA; Schöndorfer G; Roth W
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1355-64. PubMed ID: 11185634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients.
    Stangier J; Su CA; Roth W
    J Int Med Res; 2000; 28(4):149-67. PubMed ID: 11014323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
    Chae DW; Son M; Kim Y; Son H; Jang SB; Seo JM; Nam SY; Park K
    Int J Clin Pharmacol Ther; 2015 Oct; 53(10):883-9. PubMed ID: 26329347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril.
    Smith DH
    Clin Ther; 2002 Oct; 24(10):1484-501. PubMed ID: 12462282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
    Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties.
    Deppe S; Böger RH; Weiss J; Benndorf RA
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):863-71. PubMed ID: 20509777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of angiotensin II receptor blockers in the dog following a single oral administration.
    Baek IH; Lee BY; Lee ES; Kwon KI
    Drug Res (Stuttg); 2013 Jul; 63(7):357-61. PubMed ID: 23539423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers.
    Stangier J; Su CA; Brickl R; Franke H
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1365-72. PubMed ID: 11185635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of genetic variability in the ABCG2 gene on ABCG2 expression, function, and interaction with AT1 receptor antagonist telmisartan.
    Deppe S; Ripperger A; Weiss J; Ergün S; Benndorf RA
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1211-7. PubMed ID: 24388985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan.
    Meredith PA
    Am J Cardiol; 1999 Jul; 84(2A):7K-12K. PubMed ID: 10437738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of telmisartan in patients with arterial hypertension : an open-label observational study.
    Michel MC; Bohner H; Köster J; Schäfers R; Heemann U
    Drug Saf; 2004; 27(5):335-44. PubMed ID: 15061687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.